Brain+ confirms imminent commercial launch of Ayla – your CST Assistant as a medical device in the UK
Copenhagen, Denmark, 25 September 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Summary: Brain+ A/S (“Brain+” or the “Company”) has to date in 2024 achieved all planned development and go-to-market milestones and is now ready for launch of Ayla – your CST Assistant in the UK. The product will launch as a UK Class I medical device software, which is a validation of the product’s clinical efficacy and safety and key to opening the doors to the dementia care market. Regulatory certification will position Ayla – your CST Assistant as the only medical device software in the UK to deliver